Beacon Biosignals
Company Mission
Beacon Biosignals is dedicated to unlocking the power of brain data to transform how neurological and psychiatric conditions are diagnosed, treated, and understood. Their AI-powered technology accelerates neuroscience innovation to bring life-changing treatments to patients faster.
Technology and Platform
Beacon uses AI-driven neurotechnology and clinical-grade sleep EEG capture technology to measure brain activity with high fidelity using FDA-cleared headbands. Their platform provides end-to-end solutions for EEG biomarkers in clinical research, aiming to improve precision neuroscience in drug development.
The platform helps identify novel biomarkers, monitor treatment effects, and stratify patients, accelerating drug development for neurological, psychiatric, and sleep disorders. Beacon also offers full-service clinical trial support to optimize trial outcomes and regulatory success.
Impact and Values
The company supports every stage of therapeutic development, delivering insights that track disease progression early, identify dose-dependent drug effects, and expand labeling claims.
Beacon Biosignals is driving innovation with a patient-focused approach and a commitment to excellence, curiosity, transparency, and urgency to get treatments to patients sooner.
Locations
Headquartered in Boston, with offices in Paris and New York, Beacon Biosignals operates with a globally distributed team united by their mission to advance brain health worldwide.